Valuation: Revvity, Inc.

Market Cap 16.97B 15.15B 14.08B 12.81B 24.1B 1,608B 24.53B 169B 66.18B 839B 63.7B 62.35B 2,684B P/E 2026 *
64.1x
P/E 2027 * 50.5x
Enterprise Value 18.96B 16.92B 15.73B 14.31B 26.92B 1,796B 27.4B 189B 73.92B 937B 71.15B 69.64B 2,998B EV / Sales 2026 *
6.65x
EV / Sales 2027 * 6.13x
Free-Float
99.74%
Yield 2026 *
0.19%
Yield 2027 * 0.18%
1 day+1.70%
1 week+1.68%
Current month+1.19%
1 month+10.36%
3 months+38.94%
6 months+66.53%
Current year+59.91%
1 week 148.83
Extreme 148.83
158
1 month 140.08
Extreme 140.08
166.25
Current year 81.22
Extreme 81.22
166.25
1 year 81.22
Extreme 81.22
166.25
3 years 79.5
Extreme 79.5
166.25
5 years 79.5
Extreme 79.5
203.16
10 years 45.35
Extreme 45.35
203.16
Manager TitleAgeSince
Chief Executive Officer 61 30/12/2019
Director of Finance/CFO 37 06/09/2022
Chief Tech/Sci/R&D Officer - 01/05/2023
Director TitleAgeSince
Chairman 68 30/12/2019
Director/Board Member 74 07/02/2012
Director/Board Member 72 27/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Sell

Controller/Auditor

-84 0.0001%
21/09/26 Sell

Chief Financial Officer

-1,631 0.0015%
16/09/26 Sell

Chief Operating Officer

-7,330 0.0066%
Change 5-day change 1-year change 3-year change Capi.($)
+1.70%+1.68%+67.94%+45.19% 16.97B
+3.46%+6.83%+31.94%+42.57% 249B
+3.03%+6.46%+12.32%+10.00% 158B
+1.81%+3.00%-1.78%+56.06% 148B
+2.65%+5.00%-54.83%-11.90% 62.32B
+1.95%+5.94%-12.00%-14.04% 49.61B
+1.91%+4.58%+20.80%+23.61% 49.83B
+5.27%+9.90%+8.93%+47.68% 48.14B
+0.89%+4.39%+25.71%+57.44% 49.06B
+1.73%+3.50%+33.62%+74.06% 42.9B
Average +2.31%+1.89%+13.27%+33.07% 87.42B
Weighted average by Cap. +2.60%+1.89%+12.52%+33.51%

Financials

2026 *2027 *
Net sales 2.85B 2.55B 2.37B 2.15B 4.05B 270B 4.12B 28.43B 11.12B 141B 10.7B 10.48B 451B 3.01B 2.68B 2.5B 2.27B 4.27B 285B 4.35B 29.97B 11.73B 149B 11.29B 11.05B 476B
Net income 274M 244M 227M 207M 389M 25.92B 396M 2.73B 1.07B 13.52B 1.03B 1.01B 43.28B 346M 309M 287M 261M 491M 32.79B 500M 3.45B 1.35B 17.11B 1.3B 1.27B 54.74B
Net Debt 1.99B 1.77B 1.65B 1.5B 2.82B 188B 2.87B 19.78B 7.74B 98.11B 7.45B 7.29B 314B 1.46B 1.3B 1.21B 1.1B 2.07B 138B 2.11B 14.53B 5.69B 72.07B 5.47B 5.36B 231B
Projected Income Statement - Annual - Revvity, Inc.
Logo Revvity, Inc.
Revvity, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows: - medical diagnosis equipment (50.1%); - analytical tools and instruments (49.9%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales break down by source of revenue between sales of products (83.7%) and services (16.3%). Net sales are distributed geographically as follows: America (44%), Europe (28.9%) and Asia (27.1%).
Employees
11,000
Date Price Change Volume
16/10/26 $154.71 +1.70% 2,369,385
14/10/26 $152.12 -1.91% 2,023,247
13/10/26 $155.08 -0.34% 1,387,588
12/10/26 $155.61 +0.93% 1,115,984
09/10/26 $154.18 +1.33% 1,224,322
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Revvity, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
152.12USD
Average target price
147.53USD
Spread / Average Target
-3.02%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Revvity, Inc.
  1. Stock Market
  2. Stocks
  3. RVTY Stock